🇺🇸 FDA
Patent

US 10655183

Carcinoma diagnosis and treatment based on ODC1 genotype

granted A61KA61K31/192A61K31/198

Quick answer

US patent 10655183 (Carcinoma diagnosis and treatment based on ODC1 genotype) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/192, A61K31/198, A61P, A61P29/00